The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884

Clinical characteristics of coronavirus disease 2019 in China

Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246

Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia

Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575

A new coronavirus associated with human respiratory disease in China

Wu, F., Zhao, S., Yu, B., Chen, Y.-M., Wang, W., Song, Z.-G., Hu, Y., Tao, Z.-W., Tian, J.-H., Pei, Y.-Y., et al. (2020) · Nature · doi:10.1038/s41586-020-2008-3 · Cited by 11,688

First case of 2019 novel coronavirus in the United States

Holshue, M. L., DeBolt, C., Lindquist, S., Lofy, K. H., Wiesman, J., Bruce, H., Spitters, C., Ericson, K., Wilkerson, S., Tural, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001191 · Cited by 6,030

Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

Fiore, A. E., Shay, D. K., Broder, K. R., Iskander, J. K., Uyeki, T. M., Mootrey, G., Bresee, J. S., & Cox, N. S. (2001) · PsycEXTRA Dataset · doi:10.1037/e548312006-001 · Cited by 5,006

Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus

Wan, Y., Shang, J., Graham, R., Baric, R. S., & Li, F. (2020) · Journal of Virology · doi:10.1128/jvi.00127-20 · Cited by 4,341

Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan

Chan, J. F., Kok, K., Zhu, Z., Chu, H., To, K. K., Yuan, S., & Yuen, K. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1719902 · Cited by 3,127

Coronavirus envelope protein: current knowledge

Schoeman, D., & Fielding, B. C. (2019) · Virology Journal · doi:10.1186/s12985-019-1182-0 · Cited by 2,149

The spike protein of SARS-CoV — a target for vaccine and therapeutic development

Du, L., He, Y., Zhou, Y., Liu, S., Zheng, B.-J., & Jiang, S. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2090 · Cited by 1,678

COVID-19 Vaccine: A comprehensive status report

Kaur, S. P., & Gupta, V. (2020) · Virus Research · doi:10.1016/j.virusres.2020.198114 · Cited by 870

The COVID-19 pandemic: a global health crisis

Pollard, C., Morran, M. P., & Nestor‐Kalinoski, A. L. (2020) · Physiological Genomics · doi:10.1152/physiolgenomics.00089.2020 · Cited by 554

Development of CRISPR as a prophylactic strategy to combat novel coronavirus and influenza

Abbott, T. R., Dhamdhere, G. R., Liu, Y., Lin, X., Goudy, L., Zeng, L., Chemparathy, A., Chmura, S. A., Heaton, N. S., Debs, R. J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.020 · Cited by 514

COVID-19 vaccines: The status and perspectives in delivery points of view

Chung, J. Y., Thone, M. N., & Kwon, Y. J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.12.011 · Cited by 375

Neutralizing Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 in Coronavirus Disease 2019 Inpatients and Convalescent Patients

Wang, X., Guo, X., Xin, Q., Pan, Y., Hu, Y., Li, J., Chu, Y., Feng, Y., & Wang, Q. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa721 · Cited by 363

Emerging treatment strategies for COVID-19 infection

Gavriatopoulou, M., Ntanasis‐Stathopoulos, I., Korompoki, E., Fotiou, D., Migkou, M., Tzanninis, I., Ψαλτοπούλου, Θ., Kastritis, E., Terpos, E., & Dimopoulos, M. A. (2020) · Clinical and Experimental Medicine · doi:10.1007/s10238-020-00671-y · Cited by 335

COVID-19 for the Cardiologist

Atri, D. S., Siddiqi, H. K., Lang, J. P., Nauffal, V., Morrow, D. A., & Bohula, E. A. (2020) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2020.04.002 · Cited by 337

SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions

Uddin, M. J., Mustafa, F., Rizvi, T. A., Loney, T., Suwaidi, H. S. A., Al-Marzouqi, A. H. H., Kamal‐Eldin, A., Alsabeeha, N. H. M., Adrian, T. E., Stefanini, C., et al. (2020) · Viruses · doi:10.3390/v12050526 · Cited by 317

Current pharmacological treatments for COVID‐19: What's next?

Scavone, C., Brusco, S., Bertini, M., Sportiello, L., Rafaniello, C., Zoccoli, A., Berrino, L., Racagni, G., Rossi, F., & Capuano, A. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15072 · Cited by 289

COVID-19: animals, veterinary and zoonotic links

Tiwari, R., Dhama, K., Sharun, K., Yatoo, M. I., Malik, Y. S., Singh, R. K., Michalak, I., Sah, R., Bonilla‐Aldana, D. K., & Rodriguez-Morales, A. J. (2020) · Veterinary Quarterly · doi:10.1080/01652176.2020.1766725 · Cited by 288

Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients

Liu, T., Luo, S., Libby, P., & Shi, G. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107587 · Cited by 276

An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study

Yang, Z., Bogdan, P., & Nazarian, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-81749-9 · Cited by 271

In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel

Gupta, M. K., Sarojamma, V., Donde, R., Gouda, G., Behera, L., & Vadde, R. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1751300 · Cited by 270

SARS-CoV-2 jumping the species barrier: Zoonotic lessons from SARS, MERS and recent advances to combat this pandemic virus

Dhama, K., Patel, S. K., Sharun, K., Pathak, M., Tiwari, R., Yatoo, M. I., Malik, Y. S., Sah, R., Rabaan, A. A., Panwar, P. K., et al. (2020) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2020.101830 · Cited by 256

An Alphavirus -derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates

Erasmus, J. H., Khandhar, A. P., O’Connor, M. A., Walls, A. C., Hemann, E. A., Murapa, P., Archer, J., Leventhal, S., Fuller, J. T., Lewis, T. B., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.abc9396 · Cited by 241

COVID-19 and SARS-CoV-2. Modeling the present, looking at the future

Estrada, E. (2020) · Physics Reports · doi:10.1016/j.physrep.2020.07.005 · Cited by 196

An update on SARS-CoV-2/COVID-19 with particular reference to its clinical pathology, pathogenesis, immunopathology and mitigation strategies

Dhama, K., Patel, S. K., Pathak, M., Yatoo, M. I., Tiwari, R., Malik, Y. S., Singh, R. P., Sah, R., Rabaan, A. A., Bonilla‐Aldana, D. K., et al. (2020) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2020.101755 · Cited by 196

Designing a multi-epitope vaccine against SARS-CoV-2: an immunoinformatics approach

Samad, A., Ahammad, F., Nain, Z., Alam, R., Imon, R. R., Hasan, M., & Rahman, M. S. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1792347 · Cited by 191

Review of Evidence Available on Hesperidin-Rich Products as Potential Tools against COVID-19 and Hydrodynamic Cavitation-Based Extraction as a Method of Increasing Their Production

Meneguzzo, F., Ciriminna, R., Zabini, F., & Pagliaro, M. (2020) · Processes · doi:10.3390/pr8050549 · Cited by 185

Potential Applications of Plant Biotechnology against SARS-CoV-2

Capell, T., Twyman, R. M., Armario-Nájera, V., K‐C., J., Schillberg, S., & Christou, P. (2020) · Trends in Plant Science · doi:10.1016/j.tplants.2020.04.009 · Cited by 185

Epitope-based chimeric peptide vaccine design against S, M and E proteins of SARS-CoV-2 etiologic agent of global pandemic COVID-19: an in silico approach

Rahman, M. S., Hoque, M. N., Islam, M. R., Akter, S., Alam, A. R.-U., Siddique, M. A., Saha, O., Rahaman, M. M., Sultana, M., Crandall, K. A., et al. (2020) · PeerJ · doi:10.7717/peerj.9572 · Cited by 166

A bacterial extracellular vesicle‐based intranasal vaccine against SARS‐CoV‐2 protects against disease and elicits neutralizing antibodies to wild‐type and Delta variants

Jiang, L., Driedonks, T. A. P., Jong, W. S. P., Dhakal, S., van Saparoea, H. B. V. D. B., Sitaras, I., Zhou, R., Caputo, C. A., Littlefield, K. E., Lowman, M., et al. (2022) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12192 · Cited by 163

Coronavirus Disease (COVID-19): Current Status and Prospects for Drug and Vaccine Development

Ita, K. B. (2020) · Archives of Medical Research · doi:10.1016/j.arcmed.2020.09.010 · Cited by 164

Nanomaterials and Nanotechnology-Associated Innovations against Viral Infections with a Focus on Coronaviruses

Nasrollahzadeh, M., Sajjadi, M., Soufi, G. J., Iravani, S., & Varma, R. S. (2020) · Nanomaterials · doi:10.3390/nano10061072 · Cited by 161

SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic

Rabaan, A. A., Al-Ahmed, S. H., Sah, R., Tiwari, R., Yatoo, M. I., Patel, S. K., Pathak, M., Malik, Y. S., Dhama, K., Singh, K. P., et al. (2020) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-020-00384-w · Cited by 157

Extensive use of face masks during COVID-19 pandemic: (micro-)plastic pollution and potential health concerns in the Arabian Peninsula

Abbasi, S. A., Khalil, A. B., & Arslan, M. (2020) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2020.09.054 · Cited by 161

COVID-19 vaccine: where are we now and where should we go?

Soleimanpour, S., & Yaghoubi, A. (2021) · Expert Review of Vaccines · doi:10.1080/14760584.2021.1875824 · Cited by 155

Burnout and its influencing factors between frontline nurses and nurses from other wards during the outbreak of Coronavirus Disease -COVID-19- in Iran

Iran, I., & Iran, I. (2020) · Investigación y Educación en Enfermería · doi:10.17533/udea.iee.v38n2e03 · Cited by 144

Consenso colombiano de atención, diagnóstico y manejo de la infección por SARS-COV-2/COVID 19 en establecimientos de atención de la salud. Recomendaciones basadas en consenso de expertos e informadas en la evidencia

Trujillo, C. H. S. (2020) · Infectio · doi:10.22354/in.v24i3.851 · Cited by 150

Dynamics of Population Immunity Due to the Herd Effect in the COVID-19 Pandemic

Clemente‐Suárez, V. J., Hormeño-Holgado, A. J., Jiménez, M., Benítez-Agudelo, J. C., Navarro-Jiménez, E., Perez-Palencia, N., Serrano, R. Y. M., Laborde-Cárdenas, C. C., & Tornero-Aguilera, J. F. (2020) · Vaccines · doi:10.3390/vaccines8020236 · Cited by 126

Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19

Saha, R. P., Sharma, A. R., Singh, M. K., Samanta, S., Bhakta, S., Mandal, S., Bhattacharya, M., Lee, S. S., & Chakraborty, C. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01258 · Cited by 118

An integrated drug repurposing strategy for the rapid identification of potential SARS-CoV-2 viral inhibitors

Trezza, A., Iovinelli, D., Santucci, A., Prischi, F., & Spiga, O. (2020) · Scientific Reports · doi:10.1038/s41598-020-70863-9 · Cited by 115

Genetic comparison among various coronavirus strains for the identification of potential vaccine targets of SARS-CoV2

Kaur, N., Singh, R., Dar, Z., Bijarnia, R. K., Dhingra, N., & Kaur, T. (2020) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2020.104490 · Cited by 115

SARS-Cov-2 infection: Response of human immune system and possible implications for the rapid test and treatment

di Mauro, G., Scavone, C., Rafaniello, C., Rossi, F., & Capuano, A. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106519 · Cited by 109

Recombinant vaccines for COVID-19

Yadav, T., Srivastava, N., Mishra, G., Dhama, K., Kumar, S., Puri, B., & Saxena, S. K. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1820808 · Cited by 105

The within-host viral kinetics of SARS-CoV-2

Li, C., Xu, J., Liu, J., & Zhou, Y. (2020) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2020159 · Cited by 98

Vitamin B12 may inhibit RNA‐dependent‐RNA polymerase activity of nsp12 from the SARS‐CoV ‐2 virus

Narayanan, N., & Nair, D. T. (2020) · IUBMB Life · doi:10.1002/iub.2359 · Cited by 90

The 2020 race towards SARS-CoV-2 specific vaccines

Karpiński, T. M. M., Ożarowski, M., Seremak‐Mrozikiewicz, A., Wolski, H., & Włodkowic, D. (2020) · Theranostics · doi:10.7150/thno.53691 · Cited by 95

Machine Learning Techniques for the Prediction of B-Cell and T-Cell Epitopes as Potential Vaccine Targets with a Specific Focus on SARS-CoV-2 Pathogen: A Review

Bukhari, S. N. H., Jain, A., Haq, E., Mehbodniya, A., & Webber, J. L. (2022) · Pathogens · doi:10.3390/pathogens11020146 · Cited by 87

Prevention and treatment of COVID‐19 disease by controlled modulation of innate immunity

Schijns, V. E. C. J., & Lavelle, E. C. (2020) · European Journal of Immunology · doi:10.1002/eji.202048693 · Cited by 84

Developing a low-cost and accessible COVID-19 vaccine for global health

Hotez, P. J., & Bottazzi, M. E. (2020) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0008548 · Cited by 83

Promising role of defensins peptides as therapeutics to combat against viral infection

Solanki, S. S., Singh, P., Kashyap, P., Sansi, M. S., & Ali, S. A. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.104930 · Cited by 86

Fight against novel coronavirus: A perspective of medicinal chemists

Amin, S. A., & Jha, T. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112559 · Cited by 83

INSIGHT: A population-scale COVID-19 testing strategy combining point-of-care diagnosis with centralized high-throughput sequencing

Wu, Q., Suo, C., Brown, T. P., Wang, T., Teichmann, S. A., & Bassett, A. R. (2021) · Science Advances · doi:10.1126/sciadv.abe5054 · Cited by 80

COVID-19: the impact of a global crisis on sustainable development research

Filho, W. L., Azul, A. M., Wall, T., de Vasconcelos, C. R. P., Salvia, A. L., Paço, A., Shulla, K., Levesque, V. R., Doni, F., Álvarez-Castañón, L. D. C., et al. (2020) · Sustainability Science · doi:10.1007/s11625-020-00866-y · Cited by 81

Epicutaneous immunization with modified vaccinia Ankara viral vectors generates superior T cell immunity against a respiratory viral challenge

Pan, Y., Liu, L., Tian, T., Zhao, J., Park, C. O., Lofftus, S. Y., Stingley, C. A., Yan, Y., Mei, S., Liu, X., et al. (2021) · npj Vaccines · doi:10.1038/s41541-020-00265-5 · Cited by 75

Potential immuno-nanomedicine strategies to fight COVID-19 like pulmonary infections

Bonam, S. R., Kotla, N. G., Bohara, R. A., Rochev, Y. A., Webster, T. J., & Bayry, J. (2020) · Nano Today · doi:10.1016/j.nantod.2020.101051 · Cited by 76

Vaccine development and therapeutic design for 2019‐nCoV/SARS‐CoV‐2: Challenges and chances

Ghaebi, M., Osali, A., Valizadeh, H., Roshangar, L., & Ahmadi, M. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29771 · Cited by 73

Severe acute respiratory syndrome‐coronavirus‐2 spike (S) protein based vaccine candidates: State of the art and future prospects

Arashkia, A., Jalilvand, S., Mohajel, N., Afchangi, A., Azadmanesh, K., Salehi-Vaziri, ‪., Fazlalipour, M., Pouriayevali, M. H., Jalali, T., Nasab, S. D. M., et al. (2020) · Reviews in Medical Virology · doi:10.1002/rmv.2183 · Cited by 73

TINJAUAN TERKAIT PENGEMBANGAN VAKSIN COVID 19

Makmun, A., & Hazhiyah, S. F. (2020) · MOLUCCA MEDICA · doi:10.30598/molmed.2020.v13.i2.52 · Cited by 70

Structural and functional modelling of SARS-CoV-2 entry in animal models

Brooke, G. N., & Prischi, F. (2020) · Scientific Reports · doi:10.1038/s41598-020-72528-z · Cited by 66

Severe Acute Respiratory Syndrome Coronavirus-2 Emergence and Its Treatment with Alternative Medicines: A Review

Ansori, A. N. M., Kharisma, V. D., Fadholly, A., Tacharina, M. R., Antonius, Y., & Parikesit, A. A. (2021) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2021.00967 · Cited by 65

IMPACT OF COVID-19 PANDEMIC ON TOURISM: RECOVERY PROPOSAL FOR FUTURE TOURISM

Deb, S. K., & Nafi, S. M. (2020) · GeoJournal of Tourism and Geosites · doi:10.30892/gtg.334spl06-597 · Cited by 64

COVID-19 - Recent advancements in identifying novel vaccine candidates and current status of upcoming SARS-CoV-2 vaccines

Yatoo, M. I., Hamid, Z., Parray, O. R., Wani, A. H., Haq, A. U., Saxena, A., Patel, S. K., Pathak, M., Tiwari, R., Malik, Y. S., et al. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1788310 · Cited by 64

Human respiratory viruses, including SARS-CoV-2, circulating in the winter season 2019–2020 in Parma, Northern Italy

Calderaro, A., Conto, F. D., Buttrini, M., Piccolo, G., Montecchini, S., Maccari, C., Martinelli, M., Maio, A. D., Ferraglia, F., Pinardi, F., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.09.1473 · Cited by 61

Plant-based vaccines and antibodies to combat COVID-19: current status and prospects

Dhama, K., Natesan, S., Yatoo, M. I., Patel, S. K., Tiwari, R., Saxena, S. K., & Harapan, H. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1842034 · Cited by 60

Genetic Variant of SARS-CoV-2 Isolates in Indonesia: Spike Glycoprotein Gene

Ansori, A. N. M., Kharisma, V. D., Muttaqin, S. S., Antonius, Y., & Parikesit, A. A. (2020) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.14.spl1.35 · Cited by 56

Genomic diversity and evolution, diagnosis, prevention, and therapeutics of the pandemic COVID-19 disease

Hoque, M. N., Chaudhury, A., Akanda, M. A. M., Hossain, M. A., & Islam, T. (2020) · PeerJ · doi:10.7717/peerj.9689 · Cited by 53

Protective humoral immunity in SARS-CoV-2 infected pediatric patients

Zhang, Y., Xu, J., Jia, R., Yi, C., Gu, W., Liu, P., Dong, X., Zhou, H., Shang, B. Z., Cheng, S., et al. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-0438-3 · Cited by 54

A review on Promising vaccine development progress for COVID-19 disease

Belete, T. M. (2020) · Vacunas (English Edition) · doi:10.1016/j.vacun.2020.05.002 · Cited by 61

In silico trial to test COVID-19 candidate vaccines: a case study with UISS platform

Russo, G. L., Pennisi, M. A., Fichera, E., Motta, S., Raciti, G., Viceconti, M., & Pappalardo, F. (2020) · BMC Bioinformatics · doi:10.1186/s12859-020-03872-0 · Cited by 56

Examining the associations between psychological flexibility, mindfulness, psychosomatic functioning, and anxiety during the covid-19 pandemic: A path analysis

Wielgus, B., Urban, W., Patriak, A., & Cichocki, Ł. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17238764 · Cited by 51

Prion-like Domains in Spike Protein of SARS-CoV-2 Differ across Its Variants and Enable Changes in Affinity to ACE2

Tetz, G. V., & Tetz, V. (2022) · Microorganisms · doi:10.3390/microorganisms10020280 · Cited by 54

Construction of Epitope-Based Peptide Vaccine Against SARS-CoV-2: Immunoinformatics Study

Kharisma, V. D., & Ansori, A. N. M. (2020) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.14.spl1.38 · Cited by 51

Immunological memory and neutralizing activity to a single dose of COVID-19 vaccine in previously infected individuals

Sasikala, M., Jaggaiahgari, S., Gujjarlapudi, D., Ravikanth, V. V., Krishna, V. V., Yelamanchili, S., Kottapalli, P., & Reddy, D. N. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.05.034 · Cited by 50

Comprehensive annotations of the mutational spectra of SARS‐CoV‐2 spike protein: a fast and accurate pipeline

Rahman, M. S., Islam, M. R., Hoque, M. N., Alam, A. S. M. R. U., Akther, M., Puspo, J. A., Akter, S., Anwar, A., Sultana, M., & Hossain, M. A. (2020) · Transboundary and Emerging Diseases · doi:10.1111/tbed.13834 · Cited by 43

Air disinfection procedures in the dental office during the COVID-19 pandemic

Tysiąc‐Miśta, M., Dubiel, A., Brzoza, K., Burek, M., & Pałkiewicz, K. (2020) · Medycyna Pracy · doi:10.13075/mp.5893.01005 · Cited by 45

Cardiovascular disease in patients with COVID-19: evidence from cardiovascular pathology to treatment

Luo, J., Zhu, X., Jian, J., Chen, X., & Yin, K. (2020) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmaa176 · Cited by 45

A comprehensive genomic study, mutation screening, phylogenetic and statistical analysis of SARS-CoV-2 and its variant omicron among different countries

Ahmad, S. U., Kiani, B. H., Abrar, M., Jan, Z., Zafar, I., Ali, Y., Alanazi, A. M., Malik, A., Rather, M. A., Ahmad, A., et al. (2022) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2022.07.002 · Cited by 45

Large-scale analysis of SARS-CoV-2 spike-glycoprotein mutants demonstrates the need for continuous screening of virus isolates

Schrörs, B., Riesgo-Ferreiro, P., Sorn, P., Gudimella, R., Bukur, T., Rösler, T., Löwer, M., & Şahin, U. (2021) · PLoS ONE · doi:10.1371/journal.pone.0249254 · Cited by 41

SARS-CoV-2 (COVID-19): New Discoveries and Current Challenges

Soufi, G. J., Hekmatnia, A., Nasrollahzadeh, M., Shafiei, N., Sajjadi, M., Iravani, P., Fallah, S., Iravani, S., & Varma, R. S. (2020) · Applied Sciences · doi:10.3390/app10103641 · Cited by 41

Biomedical application, drug delivery and metabolic pathway of antiviral nanotherapeutics for combating viral pandemic: A review

Mukherjee, S., Mazumder, P., Joshi, M. N., Joshi, C. G., Dalvi, S. V., & Kumar, M. (2020) · Environmental Research · doi:10.1016/j.envres.2020.110119 · Cited by 42

State-of-the-Art of Nanodiagnostics and Nanotherapeutics against SARS-CoV-2

Derakhshan, M. A., Amani, A., & Majidi, R. F. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c22381 · Cited by 42

Surface engineering of personal protective equipments (PPEs) to prevent the contagious infections of SARS-CoV-2

Pandey, L. M. (2020) · Surface Engineering · doi:10.1080/02670844.2020.1801034 · Cited by 41

Ensemble Machine Learning Model to Predict SARS-CoV-2 T-Cell Epitopes as Potential Vaccine Targets

Bukhari, S. N. H., Jain, A., Haq, E., Mehbodniya, A., & Webber, J. L. (2021) · Diagnostics · doi:10.3390/diagnostics11111990 · Cited by 40

The Impact of COVID-19 on Liver Injury

Dawood, R. M., Salum, G. M., & El-Meguid, M. A. (2021) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2021.11.001 · Cited by 39

A new SEAIRD pandemic prediction model with clinical and epidemiological data analysis on COVID-19 outbreak

Liu, X., Fong, S. J., Dey, N., Crespo, R. A. G., & Herrera‐Viedma, E. (2021) · Applied Intelligence · doi:10.1007/s10489-020-01938-3 · Cited by 39

Vaccine design and delivery approaches for COVID-19

Shahzamani, K., Mahmoudian, F., Ahangarzadeh, S., Ranjbar, M. M., Beikmohammadi, L., Bahrami, S., Mohammadi, E., Esfandyari, S., Alibakhshi, A., & Javanmard, S. H. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108086 · Cited by 41

Applying high throughput and comprehensive immunoinformatics approaches to design a trivalent subunit vaccine for induction of immune response against emerging human coronaviruses SARS-CoV, MERS-CoV and SARS-CoV-2

Rahmani, A., Baee, M., Saleki, K., Moradi, S., & Nouri, H. R. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1876774 · Cited by 39

An insight into the epitope-based peptide vaccine design strategy and studies against COVID-19

Topuzoğulları, M., Acar, T., Arayıcı, P. P., Uçar, B., Ugurel, E., Abamor, E. Ş., Arasoğlu, T., Turgut‐Balik, D., & Derman, S. (2020) · TURKISH JOURNAL OF BIOLOGY · doi:10.3906/biy-2006-1 · Cited by 36

An overview of key potential therapeutic strategies for combat in the COVID-19 battle

Das, G., Ghosh, S., Garg, S., Ghosh, S., Jana, A., Samat, R., Mukherjee, N., Roy, R., & Ghosh, S. (2020) · RSC Advances · doi:10.1039/d0ra05434h · Cited by 37

Ritonavir may inhibit exoribonuclease activity of nsp14 from the SARS-CoV-2 virus and potentiate the activity of chain terminating drugs

Narayanan, N., & Nair, D. T. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.12.038 · Cited by 35

Newcastle Disease Virus-Like Particles Displaying Prefusion-Stabilized SARS-CoV-2 Spikes Elicit Potent Neutralizing Responses

Yang, Y., Shi, W., Abiona, O. M., Nazzari, A. F., Olia, A. S., Ou, L., Phung, E., Stephens, T., Tsybovsky, Y., Verardi, R., et al. (2021) · Vaccines · doi:10.3390/vaccines9020073 · Cited by 36

National routine adult immunisation programmes among World Health Organization Member States: an assessment of health systems to deploy COVID-19 vaccines

Williams, S. R., Driscoll, A. J., LeBuhn, H. M., Chen, W. H., Neuzil, K. M., & Ortiz, J. R. (2021) · Eurosurveillance · doi:10.2807/1560-7917.es.2021.26.17.2001195 · Cited by 35

GalNAc-siRNA conjugates: Prospective tools on the frontier of anti-viral therapeutics

Thangamani, L., Balasubramanian, B., Easwaran, M., Natarajan, J., Pushparaj, K., Meyyazhagan, A., & Piramanayagam, S. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105864 · Cited by 37

Evaluation on the use of COVID-19 single-use face masks to improve the properties of hot mix asphalt

Goli, A., & Sadeghi, P. (2022) · Road Materials and Pavement Design · doi:10.1080/14680629.2022.2072376 · Cited by 35

The rapid progress in COVID vaccine development and implementation

Barrett, A. D. T., Titball, R. W., MacAry, P. A., Rupp, R. E., von Messling, V., Walker, D. H., & Fanget, N. V. J. (2022) · npj Vaccines · doi:10.1038/s41541-022-00442-8 · Cited by 35

Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike ProteinsPreprint

Zhang, Y., Zhao, W., Mao, Y., Chen, Y., Wang, S., Zhong, Y., Su, T., Gong, M., Du, D., Lu, X., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.28.013276 · Cited by 37

A Putative Prophylactic Solution for COVID-19: Development of Novel Multiepitope Vaccine Candidate against SARS-COV-2 by Comprehensive Immunoinformatic and Molecular Modelling Approach

Rehman, H. M., Mirza, M. U., Ahmad, M. A., Saleem, M., Froeyen, M., Ahmad, S., Gul, R., Alghamdi, H. A., Aslam, M., Sajjad, M., et al. (2020) · Biology · doi:10.3390/biology9090296 · Cited by 32

SARS-CoV-2 vaccine candidates in rapid development

Li, L.-F., Guo, P., Zhang, X., Yu, Z.-D., Zhang, W.-C., & Sun, H.-Q. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1804777 · Cited by 36

COVID-19: A methyl-group assault?

McCaddon, A., & Regland, B. (2021) · Medical Hypotheses · doi:10.1016/j.mehy.2021.110543 · Cited by 31

In Silico Modeling as a Perspective in Developing Potential Vaccine Candidates and Therapeutics for COVID-19

Barghash, R. F., Fawzy, I. M., Chandrasekar, V., Singh, A. V., Katha, U., & Mandour, A. A. (2021) · Coatings · doi:10.3390/coatings11111273 · Cited by 31

Development of CRISPR as a prophylactic strategy to combat novel coronavirus and influenzaPreprint

Abbott, T. R., Dhamdhere, G. R., Liu, Y., Lin, X., Goudy, L., Zeng, L., Chemparathy, A. G., Chmura, S. A., Heaton, N. S., Debs, R. J., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.13.991307 · Cited by 30

Single-dose replicating RNA vaccine induces neutralizing antibodies against SARS-CoV-2 in nonhuman primatesPreprint

Erasmus, J. H., Khandhar, A. P., Walls, A. C., Hemann, E. A., O’Connor, M. A., Murapa, P., Archer, J. F., Leventhal, S. S., Fuller, J., Lewis, T. B., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.28.121640 · Cited by 30

The impact of the SARS‐CoV‐2 infection, with special reference to the hematological setting

Sica, A., Casale, D., Rossi, G., Casale, B., Ciccozzi, M., Fasano, M., Ciotti, M., Sagnelli, E., Papa, A., & Sagnelli, C. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26197 · Cited by 28

CoronaVR: A Computational Resource and Analysis of Epitopes and Therapeutics for Severe Acute Respiratory Syndrome Coronavirus-2

Gupta, A., Khan, S., Choudhury, S., Mukhopadhyay, A., Sakshi, Rastogi, A., Thakur, A., Kumari, P., Kaur, M., Shalu, et al. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01858 · Cited by 28

Novel coronavirus pathogen in humans and animals: an overview on its social impact, economic impact, and potential treatments

Akter, R., Rahman, M. H., Bhattacharya, T., Kaushik, D. K., Mittal, V., Parashar, J., Kumar, K., Kabir, M. T., & Tagde, P. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-16809-8 · Cited by 28

Effectiveness of mRNA, protein subunit vaccine and viral vectors vaccines against SARS-CoV-2 in people over 18 years old: a systematic review

Sandoval, C., Guerrero, D., Muñoz, J., Godoy, K., Souza‐Mello, V., & Farías, J. G. (2022) · Expert Review of Vaccines · doi:10.1080/14760584.2023.2156861 · Cited by 30

Potential of Lactoferrin in the Treatment of Lung Diseases

Kaczyńska, K., Jampolska, M., Wojciechowski, P., Sulejczak, D., Andrzejewski, K., & Zając, D. (2023) · Pharmaceuticals · doi:10.3390/ph16020192 · Cited by 28

Investigating the potential antiviral activity drugs against SARS-CoV-2 by molecular docking simulation

El-hoshoudy, A. N. (2020) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2020.113968 · Cited by 26

Vaccines and Treatment Strategies for SARS-COV-2Preprint

Sarkar, A., & Maulik, U. (2020) · doi:10.31219/osf.io/3qzm2 · Cited by 2

Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update

Anand, U., Jakhmola, S., Indari, O., Jha, H. C., Chen, Z., Tripathi, V. S., & de la Lastra, J. M. P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.658519 · Cited by 84

SARS-CoV-2 Leading Vaccine Candidates: Progress and Development

Amraiz, D., Fatima, M. T., & Navid, M. T. (2020) · Life and Science · doi:10.37185/lns.1.1.153 · Cited by 2

Targets and strategies for vaccine development against SARS-CoV-2

Malik, J. A., Mulla, A. H., Farooqi, T., Pottoo, F. H., Anwar, S., & Rengasamy, K. R. R. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111254 · Cited by 81

Vaccination strategies to combat novel corona virus SARS-CoV-2

Pandey, S. C., Pande, V., Sati, D., Upreti, S., & Samant, M. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117956 · Cited by 125